CDKN2A and head and neck squamous cell carcinoma: Nevertheless, studies reporting long-term oncologic results of subgroups defined by p16- and HPV-status combined are rare [19–24], even though a meta-analysis by Albers et al. included 24 studies that investigated the survival of patients with HNSCC and evaluated p16- and HPV-status [24].